WallStreetZenWallStreetZen

NASDAQ: CRGX
Cargo Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for CRGX

Based on 5 analysts offering 12 month price targets for Cargo Therapeutics Inc

Min Forecast
$3.00-34.78%
Avg Forecast
$15.00+226.09%
Max Forecast
$33.00+617.39%

Should I buy or sell CRGX stock?

Based on 5 analysts offering ratings for Cargo Therapeutics Inc.

Buy
Strong Buy
1 analysts 20%
Buy
1 analysts 20%
Hold
3 analysts 60%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although CRGX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates CRGX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their CRGX stock forecasts and price targets.

CRGX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-01-30
lockedlocked$00.00+00.00%2025-01-30
lockedlocked$00.00+00.00%2025-01-30
lockedlocked$00.00+00.00%2024-11-15
lockedlocked$00.00+00.00%2024-11-13

1 of 1

Forecast return on equity

Is CRGX forecast to generate an efficient return?

Company
-55.61%
Industry
153.19%
Market
81.87%
CRGX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is CRGX forecast to generate an efficient return on assets?

Company
-48.38%
Industry
36.07%
CRGX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

CRGX earnings per share forecast

What is CRGX's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$2.71
Avg 2 year Forecast
-$2.49
Avg 3 year Forecast
-$2.97

CRGX revenue forecast

What is CRGX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$5.0M
Avg 2 year Forecast
$10.3M
Avg 3 year Forecast
$235.0M

CRGX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CRGX$4.60$15.00+226.09%Buy
CADL$4.51$21.00+365.63%Strong Buy
PROK$0.73N/AN/A
LXRX$0.58$3.67+537.74%Buy
FHTX$3.90$12.33+216.23%Strong Buy
View Top Biotech Stocks

Cargo Therapeutics Stock Forecast FAQ

Is Cargo Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: CRGX) stock is to Buy CRGX stock.

Out of 5 analysts, 1 (20%) are recommending CRGX as a Strong Buy, 1 (20%) are recommending CRGX as a Buy, 3 (60%) are recommending CRGX as a Hold, 0 (0%) are recommending CRGX as a Sell, and 0 (0%) are recommending CRGX as a Strong Sell.

If you're new to stock investing, here's how to buy Cargo Therapeutics stock.

What is CRGX's earnings growth forecast for 2025-2027?

(NASDAQ: CRGX) Cargo Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.17%.

Cargo Therapeutics's earnings in 2025 is -$167,502,000.On average, 6 Wall Street analysts forecast CRGX's earnings for 2025 to be -$124,649,944, with the lowest CRGX earnings forecast at -$202,630,419, and the highest CRGX earnings forecast at -$57,565,460. On average, 4 Wall Street analysts forecast CRGX's earnings for 2026 to be -$114,670,396, with the lowest CRGX earnings forecast at -$164,867,477, and the highest CRGX earnings forecast at -$76,446,931.

In 2027, CRGX is forecast to generate -$136,545,271 in earnings, with the lowest earnings forecast at -$159,341,193 and the highest earnings forecast at -$113,749,349.

What is CRGX's revenue growth forecast for 2025-2027?

(NASDAQ: CRGX) Cargo Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 65.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.

Cargo Therapeutics's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast CRGX's revenue for 2025 to be $229,340,793, with the lowest CRGX revenue forecast at $229,340,793, and the highest CRGX revenue forecast at $229,340,793. On average, 1 Wall Street analysts forecast CRGX's revenue for 2026 to be $474,339,390, with the lowest CRGX revenue forecast at $474,339,390, and the highest CRGX revenue forecast at $474,339,390.

In 2027, CRGX is forecast to generate $10,823,227,527 in revenue, with the lowest revenue forecast at $10,823,227,527 and the highest revenue forecast at $10,823,227,527.

What is CRGX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: CRGX) forecast ROA is -48.38%, which is lower than the forecast US Biotechnology industry average of 36.07%.

What is CRGX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year CRGX price target, the average CRGX price target is $15.00, with the highest CRGX stock price forecast at $33.00 and the lowest CRGX stock price forecast at $3.00.

On average, Wall Street analysts predict that Cargo Therapeutics's share price could reach $15.00 by Jan 30, 2026. The average Cargo Therapeutics stock price prediction forecasts a potential upside of 226.09% from the current CRGX share price of $4.60.

What is CRGX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: CRGX) Cargo Therapeutics's current Earnings Per Share (EPS) is -$3.72. On average, analysts forecast that CRGX's EPS will be -$2.71 for 2025, with the lowest EPS forecast at -$4.40, and the highest EPS forecast at -$1.25. On average, analysts forecast that CRGX's EPS will be -$2.49 for 2026, with the lowest EPS forecast at -$3.58, and the highest EPS forecast at -$1.66. In 2027, CRGX's EPS is forecast to hit -$2.97 (min: -$3.46, max: -$2.47).

What is CRGX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: CRGX) forecast ROE is -55.61%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.